Home -> Law Blog Directory -> Intellectual Property Law Blogs -> TinytechIP
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: TinytechIPMemristor Patent ReExams and Prior Art
There are actually several material examples of memristive materials dating back to the the 1960's such as discussed by the article "Switching Phenomena in Titanium Oxide Thin Films," by Argall. However, some of the companies which have been patenting around the concept of ReRAM and memristors have not adequately considered the prior art. Over the past year I have taken a look at several of the companies and patents related to memristors and ReRAM and have begun to compile information on patents which appear to have issued without considering prior art relevant to 35 USC 102 (novelty) or 35 USC 103 (obviousness). In some extreme cases I have filed Ex Parte ReExams for patents which clearly fail to meet patentability standards.
A copy of the Ex Parte ReExam filings as well as copies of filings of prior art under 37 CFR 1.501 is available at this link. A discussion of the business landscape of memristive electronics is available here.
Full post as published by TinytechIP on January 23, 2011 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment
Qualcomm Settles Patent Suit for $891 Million
The Princeton Review
$2.6 million settlement reached in patent infringement case.

Latest Ex Parte Reexamination Statistics from the PTO
Are Appeals from Reexamination Unlikely to Succeed
Rule from 1880s Against Broadening Amendments In Reexams Is Non-Precendential.
Assessing patent validity: Prior art can anticipate patent claim even if claim is non-obvious
MMP Portfolio Prevails After Multiple Reexams







